Physician profile
James Flatt
NPI 1629022975
$8,734.34
in general payments reported to CMS, 2019-2025
49 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,719 · 2020: $828 · 2021: $1,425 · 2022: $1,664 · 2023: $1,604 · 2024: $1,355 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,098.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,525.82 | 2019-2024 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $791.94 | 2023-2024 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $716.60 | 2019-2024 | Xiaflex, Aveed |
| Antares Pharma, INC. | $423.05 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Allergan, INC. | $417.98 | 2019-2022 | |
| Abbvie INC. | $413.61 | 2019-2024 | |
| Pfizer INC. | $372.09 | 2019-2024 | |
| Urovant Sciences INC | $344.33 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $337.23 | 2019-2021 | |
| Coloplast Corp | $287.55 | 2019-2024 | Titan |
| Procept Biorobotics Corporation | $286.66 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Tolmar Pharmaceuticals, INC. | $286.57 | 2019-2022 | |
| Boston Scientific Corporation | $206.59 | 2019-2024 | Rezum Generator, Ams 700 Cxr Rte Kit, Lumenis Pulse 120h |
| Myriad Genetic Laboratories, INC. | $185.39 | 2020-2024 | Prolaris |
| Janssen Biotech, INC. | $177.84 | 2019-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $168.77 | 2019-2023 | |
| Rochester Medical Corporation | $161.66 | 2019-2021 | |
| Medtronic, INC. | $138.45 | 2021-2025 | Interstim |
| Ferring Pharmaceuticals INC. | $136.15 | 2019-2020 | |
| Halozyme INC | $127.56 | 2023 | |
| Urogen Pharma, INC. | $112.90 | 2021-2024 | Jelmyto |
| Tolmar, INC. | $110.03 | 2023-2024 | |
| Myovant Sciences INC. | $100.73 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $96.63 | 2023-2024 | Trelstar |
| Laborie Medical Technologies Corp. | $76.12 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $74.60 | 2023-2025 | Itind System, Olympus, Bovie |
| Axonics, INC. | $68.68 | 2022-2023 | Axonics, Bulkamid |
| Mission Pharmacal Company | $55.53 | 2022-2023 | Uribel |
| Travere Therapeutics, INC. | $46.10 | 2019-2022 | |
| Blue Earth Diagnostics | $44.47 | 2019-2021 | |
| Conmed Corporation | $41.02 | 2021-2023 | Airseal |
| Endo USA, INC. | $38.87 | 2024 | Xiaflex |
| Clarus Therapeutics INC. | $36.02 | 2021 | |
| Aytu Biopharma, INC. | $35.08 | 2019 | |
| Convatec INC. | $29.64 | 2021 | |
| Janssen Scientific Affairs, LLC | $28.05 | 2019 | |
| Accord Healthcare, INC. | $23.97 | 2024 | |
| Calyxo, INC. | $21.96 | 2024 | Cvac Aspiration System |
| 180 Medical, INC. | $20.99 | 2020 | |
| Merck Sharp & Dohme LLC | $20.45 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.31 | 2022 | |
| Abbott Laboratories | $18.29 | 2022 | |
| Progenics Pharmaceuticals, INC. | $17.63 | 2023 | Pylarify |
| Ethicon US, LLC | $17.40 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.24 | 2021 | |
| Novo Nordisk INC | $15.90 | 2024 | |
| Zyla Life Sciences, INC. | $15.22 | 2019 | |
| Eisai INC. | $14.58 | 2021 | |
| Photocure INC | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Flatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.